Smith And Nephew Plc (SNN) Return on Assets ROA from the fourth quarter of 2025 to fourth quarter of 2024 and for the year 2025, Average High and Low, Fundamental Ratios from Dec 31 2025 to Dec 31 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Smith and Nephew Plc  (NYSE: SNN)


Smith And Nephew Plc's ROA from the fourth quarter of 2025 to the fourth quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Smith And Nephew Plc's ROA in the fourth quarter of 2025?
Smith and Nephew Plc achieved a return on average assets (ROA) of 5.98 % in its fourth quarter of 2025, this is above SNN's average return on assets of 4.8%.
Smith And Nephew Plc assets over the 12 months ending in its fourth quarter of 2025 are valued at $10,457 million

ROA has improved compared to 3.76% in the third quarter of 2025, due to net income growth.

However, within the Healthcare sector 165 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2025 from to 1205.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Total Assets Change -15.97 % 0.99 % 0.99 % 0.99 % -0.1 %
Y / Y Net Income Change 51.7 % - - - 56.65 %
Net Income (TTM) in million 625 412 412 412 412
Return On Assets (TTM) 5.98 % 3.76 % 3.77 % 3.78 % 3.79 %
SNN's Total Ranking # 1205 # # # # 1615
Total Assets (TTM) in million 10,457 10,457 10,457 10,457 12,445
Seq. Total Assets Change 0 % 0 % 0 % -15.97 % 20.2 %
Seq. Net Income Change - - - - -

SNN's 5 Years Annual ROA >> Back to SNN Management Effectiveness >> Compare SNN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 46
Sector # 166
Overall # 1198

Return On Assets Statistics
High Average Low
8.23 %
4.8 %
2.24 %
(Dec 31 2018)   (Dec 31 2022)





Financial Statements
Smith And Nephew Plc's Assets $ 10,457 million SNN's Balance sheet
Smith And Nephew Plc's Income $ 625 million Quarterly SNN's Income Statement
SNN's Income by Division See SNN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 0.4 % -0.1 % 30.89 % -6.7 % -2.97 %
Total Assets in million 12,495 12,445 12,458 9,518 10,201
Y / Y Net Income Change 51.7 % 56.65 % 17.94 % -57.44 % 16.96 %
Net Income in million 625 412 263 223 524
Annual Return On Assets 5 % 3.31 % 2.11 % 2.34 % 5.14 %

SNN's 5 Years Annual ROA >> Back to SNN Management Effectiveness >> Compare SNN ROA to its Competitors



Comment on SNN's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 5 % compared to prior year, due to annual net income growth of 51.7 % to $625.00 million, while value of Smith And Nephew Plc's overall assets grew just by 0.4 % to $12,495.00 million, compared to $12,495.00 a year before.


More Return On Assets Ratios
SNN's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SNN's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SNN's Competitors
Subscribers only: Roa for Smith And Nephew Plc's Suppliers
Subscribers only: Return On Assets for SNN's Customers

You may also want to know
SNN's Roi SNN's Inventory Turnover Ratio SNN's Growth Rates SNN's Dividend Comparisons
SNN's Profitability Ratios SNN's Asset Turnover Ratio SNN's Dividend Growth
SNN's Roe SNN's Valuation Ratios SNN's Financial Strength Ratios SNN's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2025, within Healthcare Sector ROA
Arrowhead Pharmaceuticals Inc   16.32 %
Vertex Pharmaceuticals Inc  16.23 %
Chemed Corporation  16.06 %
Mimedx Group Inc   15.89 %
Sbc Medical Group Holdings Incorporated  15.69 %
Indivior Pharmaceuticals Inc   15.43 %
Puma Biotechnology Inc   15.36 %
Argenx Se  14.88 %
Gilead Sciences Inc   14.82 %
Merck and Co Inc   14.64 %
Intuitive Surgical Inc   14.53 %
Strata Critical Medical Inc   14.15 %
Halozyme Therapeutics Inc   14.09 %
Black Diamond Therapeutics Inc   13.91 %
Johnson and Johnson  13.76 %
Harmony Biosciences Holdings inc   13.67 %
Illumina Inc   13.55 %
Waters Corporation  13.35 %
Keros Therapeutics Inc   13.27 %
Prestige Consumer Healthcare Inc   13.25 %
Spero Therapeutics Inc   13.04 %
Hca Healthcare Inc   12.98 %
Novartis Ag  12.59 %
Embecta Corp   12.51 %
Sab Biotherapeutics Inc   12.51 %
Carlisle Companies Incorporated  12.51 %
Aveanna Healthcare Holdings Inc   12.41 %
West Pharmaceutical Services Inc   12.38 %
Inmode Ltd   12.24 %
Dexcom Inc   11.98 %

Date modified: 2026-09-08T15:11:39+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.